2
272 J . Org. Chem., Vol. 61, No. 7, 1996
Harvey and Sigano
+
LRMS EI m/z (%) 191 (M , 10), 135 (100), 107 (14), 92 (21), 77
(50.0 mg, 0.205 mmol) and 14a (103 mg, 0.307 mmol) in THF
gave 16a (49.0 mg, 74%): mp ) 73-75 °C; H NMR (500 MHz,
6 6
C D , rt, approximately a 1:1 mixture of amide rotamers) δ
+
1
(
24); HRMS (EI) calcd for C11
91.0935.
Gen er a l P r oced u r e for th e P r ep a r a tion of N-Allyl-N-
p r op a r gyla m id es (13a -c). To a solution of the N-allylben-
zamide in THF was added NaH (80% dispersion in mineral
oil) followed by propargyl bromide (80% in toluene). After 36
h, the reaction mixture was quenched with H
with Et O. The combined organics were dried over K
concentrated in vacuo, and chromatographed on silica gel to
give the N-allyl-N-propargylamide.
N-Allyl-N-p r op a r gyl-4-n itr oben za m id e (13a ). Follow-
ing the general procedure, N-allyl-4-nitrobenzamide (2.90 g,
H
13NO
2
(M ) 191.0946, found
1
0.14 (t, J ) 4.4 Hz, 1 H), 0.20-0.27 (m, 3 H), 0.76 (t, J ) 7.3
Hz, 3H), 0.80-0.88 (m, 5 H containing 0.83 (t, J ) 7.3 Hz, 3
H), 1.10 (sextet, J ) 7.3 Hz, 2 H), 1.17 (sextet, J ) 7.3 Hz, 2
H), 1.37 (pentet, J ) 7.3 Hz, 2 H), 1.45 (pentet, J ) 7.3 Hz, 2
H), 1.80 (d, J ) 17.6 Hz, 1 H), 1.84-1.93 (m, 6 H), 2.10 (d, J
) 17.6 Hz, 1 H), 2.82 (d, J ) 10.3 Hz, 1 H), 3.06 (d, J ) 10.3
Hz, 1 H) 3.18 (dd, J ) 10.3, 3.9 Hz, 1 H), 3.27 (d, J ) 11.7 Hz,
1 H), 3.31 (d, J ) 10.3 Hz, 1 H), 3.40 (dd, J ) 11.7, 3.9 Hz, 1
H), 4.23 (d, J ) 11.7 Hz, 1 H), 4.32 (d, J ) 11.7 Hz, 1 H), 6.99
2
O and extracted
3
CO ,
2
2
(
d, J ) 8.3 Hz, 2 H), 7.04 (d, J ) 8.3 Hz, 2 H), 7.65 (d, J ) 8.8
Hz, 2 H), 7.71 (d, J ) 8.3 Hz, 2 H); IR (neat) 1713, 1634, 1523
cm ; LRMS EI m/z (%) 330 (M , 6), 245 (35), 150 (100), 104
1
4.1 mmol) in THF (50 mL) was treated with NaH (80%
dispersion in mineral oil, 507 mg, 16.9 mmol) and propargyl
bromide (80% in toluene, 9.41 mL, 84.5 mmol) to give 13a (2.96
-
1
+
+
(
45); HRMS (CI, CH
found 331.1662. Anal. (C18
5â)-N-Ben zoyl-1â-(2-oxoh exa n yl)-3-a za bicyclo[3.1.0]-
4
) calcd for C18
H
23
N
2
O
4
(MH ) 331.1658,
1
22 2 4
H N O ) C, H, N.
g, 86%): mp ) 41-42 °C; H NMR (300 MHz, C
6
D
6
, 80 °C) δ
(
1
5
.91 (t, J ) 2.3 Hz, 1 H), 3.79 (br s, 4 H), 4.91-4.97 (m, 2 H),
h exa n e (16b). Following the general procedure, 13b (50.0
mg, 0.251 mmol) and 14a (127 mg, 0.380 mmol) were heated
in THF for 1 h to give 16b (40.1 mg, 56%): 1H NMR (300 MHz,
.42-5.55 (m, 1 H), 7.08 (d, J ) 8.5 Hz, 2 H), 7.71 (d, J ) 8.5
1
3
Hz, 2H); C NMR (75 MHz, C
6
D
6
, 70 °C) δ 49.2, 72.8, 78.8,
1
3
(
18.2, 123.6, 127.9, 132.5, 141.8, 148.8, 168.6; IR (neat) 3291,
081, 2120, 1643 cm-1; LRMS EI m/z (%) 243 (M - 1, 4), 205
+
C
6
D
6
, 80 °C) δ 0.25-0.34 (m, 2 H), 0.78 (t, J ) 7.3 Hz, 3 H),
0.96 (dt, J ) 7.8, 3.9 Hz, 1 H), 1.15 (sextet, J ) 7.3 Hz, 2 H),
.41 (pentet, J ) 7.3 Hz, 2 H), 1.98 (t, J ) 7.2 Hz, 2 H), 2.08
(s, 2 H), 3.25 (d, J ) 11.0 Hz, 1 H), 3.39 (dd, J ) 10.9, 3.6 Hz,
+
13), 203 (6), 150 (100). HRMS (EI) calcd for C13
H
12
N
2
O
3
(M )
1
2
44.0848, found 244.0848. Anal. (C13
N-Allyl-N-p r op a r gylben za m id e (13b). Following the
general procedure, a solution of N-allylbenzamide (2.46 g, 15.3
mmol) in THF (50 mL) was treated with NaH (550 mg, 80%
dispersion in mineral oil, 18.3 mmol) and propargyl bromide
H N O ) C, H, N.
12 2 3
1
7
1
H) 3.5-4.2 (very br s, 2 H), 7.06-7.08 (m, 3 H), 7.38-7.42
-
1
(m, 2 H); IR (neat) 1713, 1630 cm ; LRMS EI m/z (%) 285
+
+
(
2
M , 2), 105 (100); HRMS (CI, CH
86.1807, found 286.1816.
5â)-N -(4-M e t h o x y b e n z o y l)-1â-(2-o x o h e x a n y l)-3-
4 2
) calcd for C18H24NO (MH )
(
80% in toluene, 5.11 mL, 45.8 mmol) to give 13b (2.59 g, 85%).
Spectral data for 13b was in agreement with that previously
(
1
7
1
a za bicyclo[3.1.0]h exa n e (16c). Following the general pro-
cedure, 13c (50.0 mg, 0.218 mmol) and 14a (110 mg, 0.327
reported.
Hz, 1 H), 3.96 (br s, 4 H), 4.94 (d, J ) 9.3 Hz, 1 H), 4.98 (d, J
15.4 Hz, 1 H), 5.57 (ddt, J ) 16.6, 10.9, 5.5 Hz, 1 H), 7.04-
6 6
H NMR (300 MHz, C D , 70 °C) δ 1.92 (t, J ) 2.3
mmol) were heated in THF for 1 h to give 16c (36.5 mg, 58%):
)
1
.06 (m, 3 H), 7.38-7.41 (m, 2 H); 1 C NMR (75 MHz, C
3
6 6
H NMR (300 MHz, C D , 80 °C) δ 0.28-0.36 (m, 2 H), 0.79 (t,
7
7
1
D ,
6 6
J ) 7.3 Hz, 3 H), 0.94-1.01 (m, 1 H), 1.16 (sextet, J ) 7.4 Hz,
2 H), 1.42 (pentet, J ) 7.4 Hz, 2 H), 2.00 (t, J ) 7.3 Hz, 2 H),
2.11 (s, 2 H), 3.29 (d, J ) 11.0 Hz, 1 H), 3.33 (s, 3 H), 3.44 (dd,
J ) 11.0, 3.9 Hz, 1 H), 3.85 (very br s, 1 H), 4.05 (very br s, 1
H), 6.68 (d, J ) 8.5 Hz, 2 H), 7.43 (d, J ) 8.6 Hz, 2 H); IR
0 °C) δ 35.9, 49.2, 72.3, 79.6, 117.7, 127.4, 128.4, 129.7, 133.3,
-
1
36.7, 170.7; IR (neat) 3291, 3082, 1641 cm ; LRMS (EI) m/z
+
(
%) 198 (M , 16), 158 (18), 105 (100), 77 (86); HRMS (EI) calcd
+
for C13
2
H12NO (M - H) 198.0919; found 198.0922.
N-Allyl-N-p r op a r gyl-4-m eth oxyben za m id e (13c). Fol-
lowing the general procedure, N-allyl-4-methoxybenzamide
560 mg, 2.93 mmol) in THF (20 mL) was treated with NaH
80% dispersion in mineral oil, 104 mg, 3.52 mmol) and
-
1
+
(
(
3
neat) 1713, 1623, 1610 cm ; LRMS EI m/z 315 (M , 1), 230
+
7), 135 (100). HRMS (CI, CH
16.1913, found 316.1909.
4 3
) for C19H26NO (MH ) calcd
(
(
propargyl bromide (80% in toluene, 0.98 mL, 8.80 mmol) to
Ack n ow led gm en t. We are grateful for support from
1
give 13c (580 mg, 87%): H NMR (300 MHz, C
.89 (t, J ) 2.0 Hz, 1 H), 3.23 (s, 3 H), 4.01 (br s, 4 H), 4.97 (d,
J ) 11.0 Hz, 1 H), 5.02 (d, J ) 18.3 Hz, 1 H), 5.62 (ddt, J )
6 6
D , 70 °C) δ
the National Institutes of Health (Grant GM 39972) and
the Alfred P. Sloan Foundation. Fellowship support to
D.M.S. from the Graduate Assistance in Areas of
National Need (GAANN) Program of the Department
of Education, is gratefully acknowledged. The 500 MHz
NMR spectrometer was purchased with assistance from
the National Institutes of Health (RR04733) and the
National Science Foundation (CHE 8814866). Mass
spectra were obtained with the assistance of Dr. Richard
Kondrat and associates at the University of California
at Riverside Mass Spectroscopy Facility.
1
1
8
5
6.7, 11.0, 5.6 Hz, 1 H), 6.64 (d, J ) 8.6 Hz, 2 H), 7.45 (d, J )
13
.7 Hz, 2 H); C NMR (75 MHz, C
6 6
D , 70 °C) δ 36.2, 49.4,
4.9, 72.1, 79.9, 114.0, 117.6, 128.8, 129.5, 133.6, 161.5, 170.6;
-
1
+
IR (neat) 3290, 3078, 1633 cm ; LRMS EI m/z 228 (M - 1,
1
C
), 190 (2), 188 (3), 135 (100), 107 (8). HRMS (EI) calcd for
+
14
H
15NO
2
(M ) 229.1103, found 229.1105.
Gen er a l P r oced u r e for “Sea led Via l” Con d ition s (16a-
c). The N-allyl-N-propargylamide derivative and the carbene
complex were dissolved in THF (20.0 mL) in a 25 mL sealable
glass vial. The vial was then sealed with a rubber-lined screw
cap and Teflon tape. After heating at 100 °C behind a blast
shield, the reaction was cooled to room temperature and
treated with 10% aqueous HCl (2 mL) for 1 h. The reaction
mixture was then concentrated in vacuo and chromatographed
on silica gel to give the indicated product.
Su p p or tin g In for m a tion Ava ila ble: Copies of H and 13C
NMR spectra for N-allyl-N-benzylamine, 5, N-allyl-N-(4-ni-
trobenzyl)-amine, 11, N-allylbenzamide, N-allyl-4-methoxy-
1
1
benzamide, N-allyl-4-nitrobenzamide, 13a , 13b, 13c, and H
NMR for 16a , 16b, and 16c (23 pages). This material is
contained in libraries on microfiche, immediately follows this
article in the microfilm version of the journal, and can be
ordered from the ACS; see any current masthead page for
ordering information.
(
5â)-N-(4-Nitr oben zoyl)-1â-(2-oxoh exan yl)-3-azabicyclo-
[
3.1.0]h exa n e (16a ). Following the general procedure, 13a
(17) This compound has been reported previously. See: Brown, S.
W.; Pauson, P. L. J . Chem. Soc., Perkin Trans. 1 1990, 1205-1209.
J O9519930